Treatment of panic disorder

American Family Physician

Volumn 71, Issue 4, 2005, Pages 733-739

  Ham, Peter ^a,b   Waters, David B ^a,b   Oliver, M Norman ^a,b,c,d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; IMIPRAMINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; SERTRALINE;

AGORAPHOBIA; ALCOHOLISM; BEHAVIOR THERAPY; DISEASE COURSE; DRUG PREFERENCE; DRUG TOLERABILITY; HUMAN; PANIC; PATIENT PARTICIPATION; REVIEW; SELF MEDICATION; SUBSTANCE ABUSE;

ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; HUMANS; PANIC DISORDER;

EID: 13944266394     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text revision. Washington, D.C.: American Psychiatric Association, 2000.
2. Roy-Byrne PP, Stein MB, Russo J, Mercier E, Thomas R, McQuaid J, et al. Panic disorder in the primary care setting: comorbidity, disability, service utilization, and treatment. J Clin Psychiatry 1999;60:492-9.
3. Kumar S, Oakley Browne M. Panic disorder. Clin Evid 2003;9:1084-90.
4. Yingling KW, Wulsin LR, Arnold LM, Rouan GW. Estimated prevalences of panic disorder and depression among consecutive patients seen in an emergency department with acute chest pain. J Gen Intern Med 1993;8:231-5.
5. Fleet RP, Dupuis G, Marchand A, Burelle D, Arsenault A, Beitman BD. Panic disorder in emergency department chest pain patients: prevalence, comorbidity, suicidal ideation, and physician recognition. Am J Med 1996;101:371-80.
6. Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy FV 3d, Hahn SR, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 1994;272:1749-56.
7. Weissman MM, Klerman GL, Markowitz JS, Ouellette R. Suicidal ideation and suicide attempts in panic disorder and attacks. N Engl J Med 1989;321:1209-14.
8. Marshall JR. Alcohol and substance abuse in panic disorder. J Clin Psychiatry 1997;58(suppl 2):46-9.
9. Otto MW, Tuby KS, Gould RA, McLean RY, Pollack MH. An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder. Am J Psychiatry 2001;158:1989-92.
10. Bakker A, van Balkom AJ, Spinhoven P. SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis. Acta Psychiatr Scand 2002;106:163-7.
11. Boyer W. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. Int Clin Psychopharmacol 1995;10:45-9.
12. Ribeiro L, Busnello JV, Kauer-Sant'Anna M, Madruga M, Quevedo J, Busnello EA, et al. Mirtazapine versus fluoxetine in the treatment of panic disorder. Braz J Med Biol Res 2001;34:1303-7.
13. Westen D, Morrison K. A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies. J Consult Clin Psychol 2001;69:875-99.
14. Gould RA, Otto MW, Pollack MH. A meta-analysis of treatment outcome for panic disorder. Clin Psychol Rev 1995;15:819-44.
15. Clum GA, Clum GA, Surls R. A meta-analysis of treatments for panic disorder. J Consult Clin Psychol 1993;61:317-26.
16. Shear MK, Houck P, Greeno C, Masters S. Emotion-focused psychotherapy for patients with panic disorder. Am J Psychiatry 2001;158:1993-8.
17. Milrod B, Busch F. Long-term outcome of panic disorder treatment. A review of the literature. J Nerv Ment Dis 1996;184:723-30.
18. Gould RA, Clum GA. Self-help plus minimal therapist contact in the treatment of panic disorder: a replication and extension. Behav Ther 1995;26:533-46.
19. Sharp DM, Power KG, Swanson V. Reducing therapist contact in cognitive behaviour therapy for panic disorder and agoraphobia in primary care: global measures of outcome in a randomised controlled trial. Br J Gen Pract 2000;50:963-8.
20. Febbraro GA, Clum GA, Roodman AA. The limits of bibliotherapy: a study of the differential effectiveness of self-administered interventions in individuals with panic attacks. Behav Ther 1999;30:209-22.
21. Clum-GA. Coping with panic: a drug-free approach to dealing with anxiety attacks. Pacific Grove, Calif.: Brooks/Cole, 1990.
22. Bowen RC, D'Arcy C, Keegan D, Senthilselvan A. A controlled trial of cognitive behavioral treatment of panic in alcoholic inpatients with comorbid panic disorder. Addict Behav 2000;25:593-7.
23. Klein DF. Flawed meta-analyses comparing psychotherapy with pharmacotherapy. Am J Psychiatry 2000;157:1204-11.
24. Bakker A, van Balkom AJ, Spinhoven P, Blaauw BM, van Dyck R. Follow-up on the treatment of panic disorder with or without agoraphobia: a quantitative review. J Nerv Ment Dis 1998;186:414-9.
25. van Balkom AJ, Bakker A, Spinhoven P, Blaauw BM, Smeenk S, Ruesink B. A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments. J Nerv Ment Dis 1997;185:510-6.
26. Barlow DH, German JM, Shear MK, Woods SW. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial [Published corrections appear in JAMA 2000;284:2450 and JAMA 2001;284:2597]. JAMA 2000;283:2529-36.
27. Mavissakalian MR, Perel JM. Duration of imipramine therapy and relapse in panic disorder with agoraphobia. J Clin Psychopharmacol 2002;22:294-9.
28. Mavissakalian MR, Perel JM. Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia. Arch Gen Psychiatry 1999;56:821-7.
29. Schmidt NB, Wollaway-Bickel K, Trakowski JH, Santiago HT, Vasey M. Antidepressant discontinuation in the context of cognitive behavioral treatment for panic disorder. Behav Res Ther 2002;40:67-73.
30. Wilkinson G, Balestrieri M, Ruggeri M, Bellantuono C. Meta-analysis of double-blind placebo-controlled trials of antidepressants and benzodiazepines for patients with panic disorders. Psychol Med 1991;21:991-8.
31. van Balkom AJ, Nauta MC, Bakker A. Meta-analysis on the treatment of panic disorder with agoraphobia: review and re-examination. Clin Psychol Psychother 1995;2:1-14.
32. Goddard AW, Brouette T, Almai A, Jetty P, Woods SW, Charney D. Early coadministration of clonazepam with sertraline for panic disorder. Arch Gen Psychiatry 2001;58:681-6.
33. Bruce TJ, Spiegel DA, Hegel MT. Cognitive-behavioral therapy helps prevent relapse and recurrence of panic disorder following alprazolam discontinuation: a long-term follow-up of the Peoria and Dartmouth studies. J Consult Clin Psychol 1999;67:151-6.